Nevilast 150 Mg/30 Mg/200 Mg Tablet
Nevilast 150 Mg/30 Mg/200 Mg Tablet is a nucleoside analogue. It is used in combination with other medications to treat HIV infection. It functions by interfering with the growth of the HIV infection.
On using this medication you may experience side effects such as nausea, joint pain, difficulty sleeping, diarrhea, cough, dizziness, swelling of the mouth, headache, reduced appetite, weakness, vomiting, darkening of the urine, numbness, mental/ mood disorders, ear pain, itchiness, sore throat and chest pain. If your reactions persist or worsen over time seek the help of your health care provider right away.
Before using this medication tell your doctor if: you are allergic to any ingredient contained within Nevilast 150 Mg/30 Mg/200 Mg Tablet, you are taking any other medications especially emtricitabine and zalcitabine, you have enlarged liver/ high levels of lactic acid/ abnormal liver functioning/ muscle problems/ kidney problems/ lactic acidosis/ nerve disorder/ pancreas problem, you are overweight, you are pregnant or are planning to become pregnant or are nursing a baby.
The dosage for this medication should be based on your medical history and current condition. The usual dose in adults for HIV infection is about 150 mg twice daily or 300 mg once daily.
-
Hiv Infection
-
Is It safe with alcohol?
Interaction with alcohol is unknown. Please consult your doctor. -
Are there any pregnancy warnings?
Lamivir s 150mg/60mg tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor. -
Are there any breast-feeding warnings?
Unknown. Human and animal studies are not available. Please consult your doctor. -
Is it safe to drive while on this medicine?
Patients may experience dizziness and/or somnolence, and they should avoid driving or operating machinery. -
Does this affect kidney function?
Caution to be advised in patients with moderate to severe impaired renal function.
Dose adjustment is required in patients with underlined renal diseases. Please consult your doctor. -
Does this affect liver function?
There is no data available. Please consult doctor before consuming the drug.
Below is the list of medicines, which have the same composition, strength and form as Nevilast 150 Mg/30 Mg/200 Mg Tablet , and hence can be used as its substitute.
- Hetero Drugs Ltd
- Hetero Drugs Ltd
- Emcure Pharmaceuticals Ltd
- Emcure Pharmaceuticals Ltd
- Sun Pharmaceutical Industries Ltd
- Veritaz Healthcare Ltd
- Sun Pharmaceutical Industries Ltd
Nevilast 150 Mg/30 Mg/200 Mg Tablet is a class of HIV nucleoside reverse transcriptase inhibitor (NRTIs) that blocks the HIV enzyme known as reverse transcriptase. It can be used for treating both HIV 1 and HIV 2 as well as hepatitis B (HBV) where stops DNA synthesis. However, Nevilast 150 Mg/30 Mg/200 Mg Tablet is used in combination with other drugs to treat these diseases.
-
Nevirapine-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 15 June 2022].Available from:
https://druginfo.nlm.nih.gov/drugportal/name/nevirapine -
Nevirapine-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 15 June 2022].Available from:
https://go.drugbank.com/drugs/DB00238 -
Lamivudine tablet,solution-DailyMed [Internet].dailymed.nlm.nih.gov 2022 [Cited 15 June 2022].Available from:
https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=lamivudine
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.